Previous CCSB Seminar Series
2010 – 2011
| Date | Speaker, Talk title |
|---|---|
| Tues 12 Jul 2011 |
Eduardo D. Sontag, Ph.D. Department of Mathematics, Rutgers “Some theoretical issues in systems biology” Host: Edward Rietman |
| Tues 17 May 2011 |
Leonora Balaj, doctoral candidate Massachusetts General Hospital “Genetic Elements in Tumor Microvesicles” Host: Nava Almog |
| Tues 19 Apr 2011 |
Kathryn Huber, M.D., Ph.D. Tufts Medical Center “Breast Cancer Initiating Cell Radioresistance: What are the FACS?” Host: Tyson McDonald |
| Tues 12 Apr 2011 |
Joao Xavier, Ph.D. Memorial Sloan-Kettering Cancer Center “Conflict and cooperation in cell populations” Host: Heiko Enderling |
| Tues 29 Mar 2011 |
Edward Rietman, Ph.D. Dana-Farber Cancer Institute, Harvard Medical School “What works and what doesn't work on large and small system models” Host: Lynn Hlatky |
| Tues 15 Mar 2011 |
Dipanjan Chowdhury, Ph.D. Dana-Farber Cancer Institute “microRNAs, DNA repair and cancer therapy” Host: Swati Girdhani |
| Tues 15 Feb 2011 |
Michael La Croix, Ph.D. University of Waterloo, Canada “All work and no play makes Jack enumerate maps” Host: Kathleen Wilkie |
| Wed 9 Feb 2010 |
Pedro R. Lowenstein, M.D., Ph.D. Gene Therapeutics Research Institute at Cedars-Sinai Medical Center, Department of Medicine and Molecular and Medical Pharmacology at UCLA “The first seven days of a brain tumor: how interactions between glioma cells, the vasculature, and the immune system shape the glioma microenvironment, and condition therapeutic responses” Host: Lynn Hlatky |
| Tues 8 Feb 2011 |
Ofra Benny, Ph.D. Harvard Medical School, Children's Hospital Boston “Polymeric antiangiogenic drug for the treatment of cancer and ocular neovascular diseases” Host: Nava Almog |
| Tues 25 Jan 2011 |
Michael Levin, Ph.D. Tufts University, Center for Regenerative and Developmental Biology “Local and long-range bioelectric signals as developmental controls of cancer” Host: Mahdokht Behravan |
| Tues 11 Jan 2011 |
Barton Kamen, M.D., Ph.D. The Cancer Institute of New Jersey, Robert Wood Johnson Medical School “Metronomic Therapy: Is It Really a New Paradigm for Chemotherapy?” Host: Giannoula Klement |
| Tues 7 Dec 2010 |
Bridget Wagner, Ph.D. Broad Institute “Chemical strategies to increase beta-cell mass” Host: Julia Fox |
| Tues 23 Nov 2010 |
James Sherley, M.D., Ph.D. Boston Biomedical Research Institute “A bioengineering approach to advancing adult stem cell-based therapeutics” Host: Afshin Beheshti |
| Tues 9 Nov 2010 |
Dipak Panigrahy, Ph.D. Harvard Medical School “Epoxyeicosatrienoic acids control angiogenesis-dependent regeneration, cancer, and metastasis” Host: Nava Almog |
| Tues 26 Oct 2010 |
Dan Duda, Ph.D. Harvard Medical School, Massachusetts General Hospital “Pursuing biomarkers of response and resistance to antiangiogenic therapy” Host: Nava Almog |
| Tues 12 Oct 2010 |
Paul Clemons, Ph.D. Broad Institute “Cheminformatic and biological performance profiling: informing library composition, screening decisions, and target identification” Host: Julia Fox |
| Tues 28 Sep 2010 |
Johannes Wolff, M.D. Floating Hospital for Children at Tufts Medical Center “Mathematic predictions in clinical medicine” Host: Giannoula Klement |